Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,530
Closed -$706K 890
2025
Q2
$706K Buy
+2,530
New +$717K 0.12% 324
2024
Q4
Sell
-4,019
Closed -$1.29M 843
2024
Q3
$1.29M Buy
+4,019
New +$1.31M 0.29% 53
2023
Q4
Sell
-997
Closed -$268K 708
2023
Q3
$268K Sell
997
-3,611
-78% -$901K 0.08% 478
2023
Q2
$1.02M Buy
4,608
+3,350
+266% +$777K 0.29% 75
2023
Q1
$304K Sell
1,258
-164
-12% -$40.3K 0.1% 397
2022
Q4
$373K Buy
+1,422
New +$381K 0.15% 267
2020
Q2
Sell
-1,184
Closed -$240K 255
2020
Q1
$240K Sell
1,184
-81
-6% -$17.7K 0.57% 54
2019
Q4
$305K Buy
+1,265
New +$279K 0.25% 190
2018
Q4
Sell
-1,503
Closed -$312K 497
2018
Q3
$312K Buy
+1,503
New +$296K 0.14% 332
2018
Q2
Sell
-7,164
Closed -$1.22M 648
2018
Q1
$1.22M Buy
7,164
+2,907
+68% +$534K 0.3% 40
2017
Q4
$740K Buy
4,257
+1,557
+58% +$276K 0.22% 139
2017
Q3
$503K Buy
+2,700
New +$478K 0.14% 294
2017
Q2
Sell
-3,916
Closed -$642K 626
2017
Q1
$642K Buy
3,916
+2,016
+106% +$335K 0.26% 107
2016
Q4
$278K Buy
1,900
+300
+19% +$45.1K 0.15% 321
2016
Q3
$267K Sell
1,600
-4,200
-72% -$710K 0.16% 293
2016
Q2
$882K Buy
+5,800
New +$902K 0.43% 18

Other funds holding AMGN

Fox Run Management's AMGN Position: Q3 2025 in Review

Fox Run Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 2,530 shares — an estimated $706K sold.

Fox Run Management first reported a position in AMGN in Q2 2016 and held it in 16 quarters. The position peaked at $1.29M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Fox Run Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Fox Run Management sold 2,530 Amgen shares in Q3 2025, an estimated $706K.
  • Fox Run Management first reported a position in Amgen in Q2 2016 and held it in 16 quarters.
  • Fox Run Management's Amgen position peaked at $1.29M in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.